Lim Patrick, Robson Mathew, Spaliviero Jenny, McTavish Kirsten J, Jimenez Mark, Zajac Jeffrey D, Handelsman David J, Allan Charles M
Andrology Laboratory, ANZAC Research Institute, Concord Hospital, Sydney, New South Wales 2139, Australia.
Endocrinology. 2009 Oct;150(10):4755-65. doi: 10.1210/en.2009-0416. Epub 2009 Jul 2.
We examined the biological importance of Sertoli cell androgen receptor (AR) genomic interaction, using a Cre-loxP approach to selectively disrupt the AR DNA-binding domain (AR-DBD). Sertoli cell (SC)-specific transgenic Abpa or AMH promoters targeted Cre-mediated inframe excision of mouse Ar exon-3, encoding the AR-DBD second zinc-finger (ZF2), generating SC-specific mutant AR(DeltaZF2) lines designated Abp.SCAR(DeltaZF2) and AMH.SCAR(DeltaZF2), respectively. Both SCAR(DeltaZF2) lines produced infertile males exhibiting spermatogenic arrest, despite normal SC numbers and immunolocalized SC nuclear AR. Adult homozygous TgCre((+/+)) SCAR(DeltaZF2) or double-TgCre((+/-)) Abp/AMH.SCAR(DeltaZF2) males displayed equivalent small testes 30% of normal size, representing maximal Cre-loxP-disruption of Sertoli AR function. Hemizygous TgCre((+/-)) vs. homozygous TgCre((+/+)) Abp.SCAR(DeltaZF2) testes were larger (47% normal size) with more postmeiotic development, indicating dose-dependent Cre-mediated disruption of SC-specific AR-DBD activity. SCAR(DeltaZF2) males exhibited adult Leydig cell hypertrophy but normal serum testosterone levels. Sertoli cell-specific Rhox5 and Spinlw1 transcription, regulated by divergent or classical androgen-response elements, respectively, were both decreased in postnatal SCAR(DeltaZF2) vs. control testes, demonstrating SC-specific AR-DBD function as early as postnatal d 5. However, Rhox5 expression declined dose-dependently, whereas Spinlw1 expression increased, in adult TgCre((+/-)) and TgCre((+/+)) SCAR(DeltaZF2) testes, revealing differential temporal control for distinct AR-regulated transcripts. Androgen-repressed Ngfr was not up-regulated in SCAR(DeltaZF2) testes, suggesting maintenance of a nonclassical mechanism independent of AR-DBD. Thus, our unique SCAR(DeltaZF2) paradigm provided dose-dependent Cre-mediated disruption of testicular development and gene expression revealing that the AR-DBD is essential for SC function and postmeiotic spermatogenesis. Nongenomic or AR-DBD-independent pathways appear secondary or play no major independent role in SC function.
我们采用Cre-loxP方法选择性破坏雄激素受体(AR)的DNA结合结构域(AR-DBD),以研究支持细胞雄激素受体基因组相互作用的生物学重要性。支持细胞(SC)特异性转基因Abpa或AMH启动子靶向Cre介导的小鼠Ar外显子3的框内切除,该外显子编码AR-DBD的第二个锌指(ZF2),分别产生支持细胞特异性突变体AR(DeltaZF2)系,命名为Abp.SCAR(DeltaZF2)和AMH.SCAR(DeltaZF2)。尽管支持细胞数量正常且免疫定位的支持细胞核AR正常,但两个SCAR(DeltaZF2)系均产生了不育雄性,表现为精子发生停滞。成年纯合TgCre((+/+)) SCAR(DeltaZF2)或双转基因TgCre((+/-)) Abp/AMH.SCAR(DeltaZF2)雄性的睾丸大小相当于正常大小的30%,显示支持细胞AR功能的Cre-loxP破坏达到最大程度。半合子TgCre((+/-))与纯合子TgCre((+/+)) Abp.SCAR(DeltaZF2)睾丸相比更大(为正常大小的47%),减数分裂后发育更多,表明Cre介导的支持细胞特异性AR-DBD活性破坏呈剂量依赖性。SCAR(DeltaZF2)雄性表现出成年睾丸间质细胞肥大,但血清睾酮水平正常。分别由不同或经典雄激素反应元件调节的支持细胞特异性Rhox5和Spinlw1转录,在出生后SCAR(DeltaZF2)睾丸与对照睾丸中均降低,表明早在出生后第5天支持细胞特异性AR-DBD就发挥功能。然而,在成年TgCre((+/-))和TgCre((+/+)) SCAR(DeltaZF2)睾丸中,Rhox5表达呈剂量依赖性下降,而Spinlw1表达增加,揭示了不同AR调节转录本的不同时间控制。雄激素抑制的Ngfr在SCAR(DeltaZF2)睾丸中未上调,提示维持了一种独立于AR-DBD的非经典机制。因此,我们独特的SCAR(DeltaZF2)模式提供了Cre介导的睾丸发育和基因表达的剂量依赖性破坏,表明AR-DBD对支持细胞功能和减数分裂后精子发生至关重要。非基因组或独立于AR-DBD的途径在支持细胞功能中似乎是次要的或不发挥主要独立作用。